Morpholine

Morpholine

SCHEMBL3142248

C1COCCN1.CCP(=O)(O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
GAA P10253 1/20 0.48
CYP2C9 P11712 1/20 0.48
ANPEP P15144 2/20 0.33
MMP2 P08253 1/20 0.33
THRB P10828 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HTT P42858 1/20 0.31
MMP1 P03956 1/20 0.30
MMP3 P08254 1/20 0.30
MMP8 P22894 1/20 0.30
LAP3 P28838 1/20 0.30
ERAP2 Q6P179 1/20 0.30
FDPS P14324 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Medronic Acid SCHEMBL8057993 0.88 KDM4E (0.50) KDM4EMEN1KMT2AGAACYP2C9
Morpholine SCHEMBL29071034 0.83 MEN1 (0.61) KDM4EMEN1KMT2AGAACYP2C9
Morpholine SCHEMBL20580623 0.83 MEN1 (0.61) KDM4EMEN1KMT2AGAACYP2C9
Morpholine SCHEMBL29377463 0.83 MEN1 (0.61) KDM4EMEN1KMT2AGAACYP2C9
Morpholine SCHEMBL7727917 0.83 MEN1 (0.61) KDM4EMEN1KMT2AGAACYP2C9
Morpholine SCHEMBL11120537 0.83 MEN1 (0.61) KDM4EMEN1KMT2AGAACYP2C9
Morpholine SCHEMBL11664356 0.82 MEN1 (0.48) KDM4EMEN1KMT2AGAACYP2C9
Morpholine SCHEMBL2852663 0.81 MEN1 (0.42) KDM4EMEN1KMT2AGAACYP2C9
Morpholine SCHEMBL2029282 0.78 MEN1 (0.55) KDM4EMEN1KMT2AGAACYP2C9
Morpholine SCHEMBL412425 0.78 MEN1 (0.55) KDM4EMEN1KMT2AGAACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2177525-A1 METAL COMPLEX COMPOUND, CANCER THERAPEUTIC COMPOSITION COMPRISING THE METAL COMPLEX COMPOUND AS ACTIVE INGREDIENT, AND INTERMEDIATE FOR PRODUCTION OF THE METAL COMPLEX COMPOUND TMRC Co., Ltd. (JP) 2010-04-21 EP disclosed